Detalhe da pesquisa
1.
ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Pediatr Nephrol
; 38(2): 403-415, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552824
2.
Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
Nephrol Dial Transplant
; 36(8): 1464-1473, 2021 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810261
3.
Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studies.
Pediatr Nephrol
; 36(7): 1785-1793, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33515281
4.
An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.
Pediatr Nephrol
; 34(1): 145-154, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30141180
5.
Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.
Pediatr Nephrol
; 34(4): 739-740, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536181
6.
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis.
Pediatr Nephrol
; 34(3): 475-486, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506144
7.
Enhancing clinical trial development for pediatric kidney diseases.
Pediatr Res
; 82(5): 727-732, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28853726
8.
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
JAMA
; 317(2): 156-164, 2017 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097356
9.
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Circulation
; 132(1): 27-39, 2015 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26059012
10.
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
J Am Soc Nephrol
; 26(6): 1466-75, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25505257
11.
Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial.
Value Health
; 18(8): 1079-87, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26686794
12.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Pharm Stat
; 14(3): 242-51, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25851955
13.
Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
BMC Nephrol
; 13: 76, 2012 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22863242
14.
Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Nephrol Dial Transplant
; 26(6): 1956-61, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947534
15.
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.
Nephrol Dial Transplant
; 26(4): 1327-39, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21148030
16.
Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis.
Front Med (Lausanne)
; 8: 592357, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33898474
17.
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients.
Nephrol Dial Transplant
; 25(6): 1916-23, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20110249
18.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Pharm Stat
; 14(4): 368, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26096896
19.
End Points for Clinical Trials in Primary Hyperoxaluria.
Clin J Am Soc Nephrol
; 15(7): 1056-1065, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165440
20.
A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet.
Pharmacoeconomics
; 36(5): 603-612, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29392552